Andreas J Flammer
Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis.
Pérez Shibayama C, Gil Cruz C, Cadosch N, Lütge M, Cheng H, De Martin A, Frischmann K, Joachimbauer A, Onder L, Papadopoulou I, Papadopoulou C, Ring S, Krebs P, P. Vu V, P. Nägele M, Rossi V, Parianos D, Zsilavecz V, Cooper L, Flammer A, Ruschitzka F, Rainer P, Schmidt D, Ludewig B. Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis. Nat Cardiovasc Res 2024; 3:301-316.
19.02.2024Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis.
19.02.2024Nat Cardiovasc Res 2024; 3:301-316
Pérez Shibayama Christian Ivan, Gil Cruz Cristina, Cadosch Nadine, Lütge Mechthild, Cheng Hung-Wei, De Martin Angelina, Frischmann Kira, Joachimbauer Anna, Onder Lucas, Papadopoulou Iliana, Papadopoulou Chrysa, Ring Sandra Stephanie, Krebs Philippe, P. Vu Vivian, P. Nägele Matthias, Rossi Valentina A, Parianos Danae, Zsilavecz Valentin W, Cooper Leslie T., Flammer Andreas J, Ruschitzka Frank, Rainer Peter P, Schmidt Dörthe, Ludewig Burkhard
Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry.
Brouwers S, Heimgartner R, Laptseva N, Aguzzi A, Ehl N, Fehr T, Hitz F, Jung H, Kälin J, Manz M, Muellhaupt B, Ruschitzka F, Seeger H, Stussi G, Zweier M, Flammer A, Gerber B, Schwotzer R. Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry. Swiss Med Wkly 2024; 154:3485.
15.02.2024Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry.
15.02.2024Swiss Med Wkly 2024; 154:3485
Brouwers Sofie, Heimgartner Raphael, Laptseva Natallia, Aguzzi Adriano, Ehl Niklas, Fehr Thomas, Hitz Felicitas, Jung Hans H, Kälin Joel, Manz Markus G, Muellhaupt Beat, Ruschitzka Frank, Seeger Harald, Stussi Georg, Zweier Markus, Flammer Andreas J, Gerber Bernhard L, Schwotzer Rahel
Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study
Enseleit F, Ruschitzka F, Lüscher T, Neidhart M, Högger P, Uhlenhut K, Matter C, Krasniqi N, Haile S, Hirt A, Kaiser P, Fröhlich G, Flammer A, Wolfrum M, Winnik S, Périat D, Sudano I, Noll G. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J 2012
11.01.2012Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study
11.01.2012Eur Heart J 2012
Enseleit Frank, Ruschitzka Frank, Lüscher Thomas F, Neidhart Michel, Högger Petra, Uhlenhut Klaus, Matter Christian M, Krasniqi Nazmi, Haile Sarah, Hirt Astrid, Kaiser Priska, Fröhlich Georg M, Flammer Andreas J, Wolfrum Mathias, Winnik Stephan, Périat Daniel, Sudano Isabella, Noll Georg
Acetaminophen increases blood pressure in patients with coronary artery disease
Sudano I, Nussberger J, Mocharla P, Landmesser U, Haile S, Corti R, Vanhoutte P, Lüscher T, Noll G, Holzmeister J, Gay S, Neidhart M, Flammer A, Périat D, Enseleit F, Hermann M, Wolfrum M, Hirt A, Kaiser P, Hurlimann D, Ruschitzka F. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation 2010; 122:1789-96.
18.10.2010Acetaminophen increases blood pressure in patients with coronary artery disease
18.10.2010Circulation 2010; 122:1789-96
Sudano Isabella, Nussberger Juerg, Mocharla Pavani, Landmesser Ulf, Haile Sarah, Corti Roberto, Vanhoutte Paul M, Lüscher Thomas F, Noll Georg, Holzmeister Johannes, Gay Steffen, Neidhart Michel, Flammer Andreas J, Périat Daniel, Enseleit Frank, Hermann Matthias, Wolfrum Mathias, Hirt Astrid, Kaiser Priska, Hurlimann David, Ruschitzka Frank